Enliven Therapeutics, Inc. ELVN
46.60 USD -1.02 (-2.14%)
As ofNov 17, 2026, 2:40 PM EST
46.05 Day range 47.75
15.14 52-week range 61.15
- YTD
- +202.60%
- 1 year
- +114.15%
Next earnings
Mar 2, 2027
Expected Mar 2, 2027. Consensus EPS estimate -0.43023.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 2, 2027 | Dec 30, 2026 | -0.47 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | -0.44786 | -0.36 | +0.09 | +19.62% |
| Aug 5, 2026 | Jun 30, 2026 | -0.38717 | -0.49 | -0.10 | -26.56% |
| May 7, 2026 | Mar 31, 2026 | -0.44 | -0.38 | +0.06 | +13.64% |
| Mar 3, 2026 | Dec 31, 2025 | -0.42 | -0.48 | -0.06 | -14.29% |
| Nov 12, 2025 | Sep 30, 2025 | -0.43 | -0.32 | +0.11 | +25.58% |
